<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03566550</url>
  </required_header>
  <id_info>
    <org_study_id>18GA006</org_study_id>
    <nct_id>NCT03566550</nct_id>
  </id_info>
  <brief_title>Gut Imaging for Function &amp; Transit in Cystic Fibrosis Study 1</brief_title>
  <acronym>GIFT-CF1</acronym>
  <official_title>A Case-Control, Observational Study of the Postprandial Changes in Magnetic Resonance Imaging Parameters of Gastrointestinal Function and Transit in People With Cystic Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nottingham University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nottingham University Hospitals NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many people with Cystic Fibrosis (CF) are troubled by symptoms from their stomach and bowels:&#xD;
      their gastrointestinal (GI) tract. Symptoms affect quality of life and can also reduce&#xD;
      people's ability to digest enough calories to remain healthy, leaving them undernourished and&#xD;
      less able to deal with other health problems such as infection.&#xD;
&#xD;
      Clinical tests to assess bowel function are limited. Many tests involve inserting a sensor or&#xD;
      camera into the bowel, so they are not suitable for long periods, and can be uncomfortable.&#xD;
      In Nottingham the investigators have developed imaging scans which can assess how someone's&#xD;
      digestion works without any invasive device. The type of scanning the investigators use is&#xD;
      called Magnetic Resonance Imaging, or MRI.&#xD;
&#xD;
      The purpose of this study is to see if those scanning methods can be used in people with CF&#xD;
      to understand their digestion and any problems they have.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a small pilot study to establish that differences in digestion between people with&#xD;
      and without CF can be quantified by repeated MR scans in fasted participants in response to&#xD;
      standardised meals.&#xD;
&#xD;
      Participants will complete questionnaires on gastrointestinal function and symptoms: the&#xD;
      PAC-SYM questionnaire, validated to assess symptom burden in adults with chronic&#xD;
      constipation; and the CF abdomen questionnaire, developed in German for use in young people&#xD;
      and adults with cystic fibrosis.&#xD;
&#xD;
      After this, participants only need to attend one study day at the Sir Peter Mansfield Imaging&#xD;
      Centre. On this day they will be asked to withhold any medicines specifically targeted to&#xD;
      alter bowel habit. This shall include laxatives but not enzyme replacement therapy. They&#xD;
      should attend on the study day having fasted since waking, other than water for essential&#xD;
      medicines.&#xD;
&#xD;
      They will have their first MRI scan fasted. After the scan they will eat a standard test&#xD;
      meal, and be scanned again first at half hour, then hour intervals until six hours after the&#xD;
      first meal. The final scan will constitute the end of the study for each participant. Each&#xD;
      session in the MRI scanner will last around 15 minutes. After each scan they will complete a&#xD;
      validated rating scale for any current symptoms: the Gastrointestinal Symptom Rating Scale&#xD;
      (GSRS).In between scans, participants will have access to a lounge with wifi and a&#xD;
      television.&#xD;
&#xD;
      Infection control requirements mean that the investigators are unable to scan more than one&#xD;
      patient with CF on a single day. Patient scans will alternate with those of a Control&#xD;
      participant. The investigators will aim to frequency match Controls with Patients for age and&#xD;
      gender.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 4, 2018</start_date>
  <completion_date type="Actual">February 20, 2019</completion_date>
  <primary_completion_date type="Actual">February 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Orocaecal Transit Time</measure>
    <time_frame>1 day of scanning</time_frame>
    <description>time taken after eating for ingested food to be identifiable in the caecum on MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastric Half Emptying Times</measure>
    <time_frame>1 day of scanning</time_frame>
    <description>volume of stomach at each time point of digestion to measure speed of gastric emptying (time taken for half the gastric contents to be emptied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Small Bowel Water Content (Corrected for Body Surface Area)</measure>
    <time_frame>1 day of scanning</time_frame>
    <description>volume of water content in small bowel representing secretions (area under the curve - timepoints at baseline then 0,30,60,90,120,150,180,240,300,360 minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colonic Volume (Corrected for Body Surface Area)</measure>
    <time_frame>1 day of scanning</time_frame>
    <description>volume of colon representing ease of chyme passage through colon (area under the curve - timepoints at baseline then 0,30,60,90,120,150,180,240,300,360 minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal Symptoms</measure>
    <time_frame>1 day of scanning</time_frame>
    <description>gastrointestinal symptoms as measured by questionnaires to monitor relationship with outcomes measured by MRI. Scale of the CFAbd-score ranges from 0-100. A low score indicates fewer gastrointestinal symptoms whilst a higher score indicates more severe and frequent gastrointestinal symptoms.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>T1 Relaxation Time of Ascending Colon Chyme</measure>
    <time_frame>1 day of scanning</time_frame>
    <description>An approximate measure of water content in chyme present in the ascending colon</description>
  </other_outcome>
  <other_outcome>
    <measure>Fat Fraction of the Ascending Colon Chyme</measure>
    <time_frame>1 day of scanning</time_frame>
    <description>A measure of fat content in chyme present in the ascending colon</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>CF</arm_group_label>
    <description>people with cystic fibrosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>people without cystic fibrosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MRI scans</intervention_name>
    <description>Repeated MRI scans imaging digestion of standard meals</description>
    <arm_group_label>CF</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Nottingham and surrounding towns&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 12 - 40 years&#xD;
&#xD;
          -  Capacity to consent, or to understand the requirements of the study where parental&#xD;
             consent is needed&#xD;
&#xD;
          -  PATIENTS: confirmed diagnosis of Cystic Fibrosis, either by sweat test or genetic&#xD;
             testing; to reduce heterogeneity, we will only enrol homozygous CF patients with the&#xD;
             most common CFTR mutation, p.Phe508del&#xD;
&#xD;
          -  CONTROLS: no clinical evidence or suspicion of Cystic Fibrosis&#xD;
&#xD;
        Exclusion Criteria:â€¢ Measurement of Forced Expiratory Volume in 1 second (FEV1) of &lt;40%&#xD;
        predicted using Global Lung Initiative criteria, according to clinical records&#xD;
&#xD;
          -  Contra-indication to MRI scanning, such as embedded metal, pacemaker&#xD;
&#xD;
          -  Unable to stop medications directly prescribed to alter bowel habit, such as laxatives&#xD;
             of anti-diarrhoeals, on the study day&#xD;
&#xD;
          -  Previous resection of any part of the gastro-intestinal tract apart from&#xD;
             appendicectomy or cholecystectomy. Surgical relief of distal ileal obstruction&#xD;
             syndrome or neonatal ileus will be permitted unless clinical records show excision of&#xD;
             intestine &gt;20cm in length.&#xD;
&#xD;
          -  Intestinal stoma&#xD;
&#xD;
          -  Diagnosis of inflammatory bowel disease or coeliac disease confirmed by biopsy&#xD;
&#xD;
          -  Gastrointestinal malignancy&#xD;
&#xD;
          -  Unable to comply with dietary restrictions required for the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Smyth, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nottingham University Hospitals National Health Service Trust</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 12, 2018</study_first_submitted>
  <study_first_submitted_qc>June 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2018</study_first_posted>
  <results_first_submitted>January 14, 2021</results_first_submitted>
  <results_first_submitted_qc>March 9, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 5, 2021</results_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share individual participant data outside the research team at this time.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/50/NCT03566550/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>51 CF patients were eligible. CF patients were approached in order of their hospital attendance and the first 12 to provide written consent were enroled into the study. 13 declined to participate and 2 withdrew consent as they did not like the standardised meals or MRI.&#xD;
12 CF patients and 12 controls completed the protocol without any adverse events. 1 further control was withdrawn and replaced as the participant was unable to complete the first standardised meal and the remaining 10 MRI scans.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Cystic Fibrosis</title>
          <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cystic Fibrosis</title>
          <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (kg)</title>
          <units>kg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" lower_limit="53" upper_limit="59"/>
                    <measurement group_id="B2" value="62" lower_limit="59" upper_limit="75"/>
                    <measurement group_id="B3" value="59" lower_limit="54" upper_limit="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height (cm)</title>
          <units>cm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="12"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="24"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="166" lower_limit="158" upper_limit="175"/>
                    <measurement group_id="B2" value="166" lower_limit="160" upper_limit="176"/>
                    <measurement group_id="B3" value="166" lower_limit="158" upper_limit="176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Orocaecal Transit Time</title>
        <description>time taken after eating for ingested food to be identifiable in the caecum on MRI</description>
        <time_frame>1 day of scanning</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cystic Fibrosis</title>
            <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
        </group_list>
        <measure>
          <title>Orocaecal Transit Time</title>
          <description>time taken after eating for ingested food to be identifiable in the caecum on MRI</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="330" lower_limit="270" upper_limit="NA">please note the upper quartile for the cystic fibrosis group states NA due to censored data after 360 minutes (MRI scans were only performed until 360 minutes).</measurement>
                    <measurement group_id="O2" value="210" lower_limit="173" upper_limit="315"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gastric Half Emptying Times</title>
        <description>volume of stomach at each time point of digestion to measure speed of gastric emptying (time taken for half the gastric contents to be emptied)</description>
        <time_frame>1 day of scanning</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cystic Fibrosis</title>
            <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
        </group_list>
        <measure>
          <title>Gastric Half Emptying Times</title>
          <description>volume of stomach at each time point of digestion to measure speed of gastric emptying (time taken for half the gastric contents to be emptied)</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97" lower_limit="71" upper_limit="128"/>
                    <measurement group_id="O2" value="80" lower_limit="66" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.3</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Small Bowel Water Content (Corrected for Body Surface Area)</title>
        <description>volume of water content in small bowel representing secretions (area under the curve - timepoints at baseline then 0,30,60,90,120,150,180,240,300,360 minutes)</description>
        <time_frame>1 day of scanning</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cystic Fibrosis</title>
            <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
        </group_list>
        <measure>
          <title>Small Bowel Water Content (Corrected for Body Surface Area)</title>
          <description>volume of water content in small bowel representing secretions (area under the curve - timepoints at baseline then 0,30,60,90,120,150,180,240,300,360 minutes)</description>
          <units>L.min/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62" lower_limit="36" upper_limit="80"/>
                    <measurement group_id="O2" value="34" lower_limit="28" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.021</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Colonic Volume (Corrected for Body Surface Area)</title>
        <description>volume of colon representing ease of chyme passage through colon (area under the curve - timepoints at baseline then 0,30,60,90,120,150,180,240,300,360 minutes)</description>
        <time_frame>1 day of scanning</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cystic Fibrosis</title>
            <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
        </group_list>
        <measure>
          <title>Colonic Volume (Corrected for Body Surface Area)</title>
          <description>volume of colon representing ease of chyme passage through colon (area under the curve - timepoints at baseline then 0,30,60,90,120,150,180,240,300,360 minutes)</description>
          <units>L.min/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="186" lower_limit="166" upper_limit="206"/>
                    <measurement group_id="O2" value="123" lower_limit="89" upper_limit="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gastrointestinal Symptoms</title>
        <description>gastrointestinal symptoms as measured by questionnaires to monitor relationship with outcomes measured by MRI. Scale of the CFAbd-score ranges from 0-100. A low score indicates fewer gastrointestinal symptoms whilst a higher score indicates more severe and frequent gastrointestinal symptoms.</description>
        <time_frame>1 day of scanning</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cystic Fibrosis</title>
            <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
          </group>
        </group_list>
        <measure>
          <title>Gastrointestinal Symptoms</title>
          <description>gastrointestinal symptoms as measured by questionnaires to monitor relationship with outcomes measured by MRI. Scale of the CFAbd-score ranges from 0-100. A low score indicates fewer gastrointestinal symptoms whilst a higher score indicates more severe and frequent gastrointestinal symptoms.</description>
          <units>CFAbd-Score units</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="5" upper_limit="25"/>
                    <measurement group_id="O2" value="7" lower_limit="3" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>T1 Relaxation Time of Ascending Colon Chyme</title>
        <description>An approximate measure of water content in chyme present in the ascending colon</description>
        <time_frame>1 day of scanning</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Fat Fraction of the Ascending Colon Chyme</title>
        <description>A measure of fat content in chyme present in the ascending colon</description>
        <time_frame>1 day of scanning</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day of MRI scanning</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cystic Fibrosis</title>
          <description>people with cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>people without cystic fibrosis&#xD;
MRI scans: Repeated MRI scans imaging digestion of standard meals</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Alan Smyth</name_or_title>
      <organization>University of Nottingham</organization>
      <phone>01158230612</phone>
      <email>alan.smyth@nottingham.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

